Xponance Inc. Decreases Stock Position in Leidos Holdings, Inc. (NYSE:LDOS)

Xponance Inc. reduced its position in Leidos Holdings, Inc. (NYSE:LDOS) by 5.8% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 23,564 shares of the aerospace company’s stock after selling 1,447 shares during the period. Xponance Inc.’s holdings in Leidos were worth $2,551,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in the company. Wellington Management Group LLP raised its holdings in Leidos by 6.2% in the 3rd quarter. Wellington Management Group LLP now owns 4,660,386 shares of the aerospace company’s stock worth $429,501,000 after acquiring an additional 272,090 shares during the last quarter. Massachusetts Financial Services Co. MA raised its holdings in Leidos by 5.9% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,044,206 shares of the aerospace company’s stock worth $280,554,000 after acquiring an additional 169,351 shares during the last quarter. FMR LLC raised its holdings in Leidos by 36.1% in the 3rd quarter. FMR LLC now owns 1,808,666 shares of the aerospace company’s stock worth $166,687,000 after acquiring an additional 479,906 shares during the last quarter. Pzena Investment Management LLC grew its position in Leidos by 320.1% in the 3rd quarter. Pzena Investment Management LLC now owns 1,246,768 shares of the aerospace company’s stock worth $114,902,000 after purchasing an additional 949,955 shares during the period. Finally, Charles Schwab Investment Management Inc. grew its position in Leidos by 1.4% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,161,653 shares of the aerospace company’s stock worth $107,058,000 after purchasing an additional 16,250 shares during the period. 76.12% of the stock is currently owned by hedge funds and other institutional investors.

Leidos Trading Up 0.9 %

Shares of Leidos stock opened at $126.03 on Tuesday. The company has a market capitalization of $17.03 billion, a P/E ratio of 88.75, a P/E/G ratio of 1.73 and a beta of 0.70. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.24 and a current ratio of 1.34. The company has a fifty day moving average of $127.01 and a 200 day moving average of $112.95. Leidos Holdings, Inc. has a fifty-two week low of $76.58 and a fifty-two week high of $131.50.

Leidos (NYSE:LDOS) last issued its earnings results on Tuesday, February 13th. The aerospace company reported $1.99 earnings per share for the quarter, topping the consensus estimate of $1.74 by $0.25. The company had revenue of $3.98 billion during the quarter, compared to the consensus estimate of $3.81 billion. Leidos had a net margin of 1.29% and a return on equity of 22.92%. Leidos’s quarterly revenue was up 7.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.83 EPS. On average, sell-side analysts anticipate that Leidos Holdings, Inc. will post 7.77 earnings per share for the current fiscal year.

Leidos Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, March 28th. Shareholders of record on Friday, March 15th were paid a $0.38 dividend. This represents a $1.52 annualized dividend and a yield of 1.21%. The ex-dividend date of this dividend was Thursday, March 14th. Leidos’s payout ratio is currently 107.04%.

Wall Street Analysts Forecast Growth

A number of research firms have commented on LDOS. Argus lifted their target price on shares of Leidos from $120.00 to $145.00 and gave the stock a “buy” rating in a research report on Wednesday, March 20th. Truist Financial lifted their target price on shares of Leidos from $135.00 to $150.00 and gave the stock a “buy” rating in a research report on Tuesday, April 9th. Royal Bank of Canada lifted their target price on shares of Leidos from $105.00 to $120.00 and gave the stock a “sector perform” rating in a research report on Wednesday, February 14th. StockNews.com raised shares of Leidos from a “buy” rating to a “strong-buy” rating in a research report on Thursday, April 18th. Finally, Jefferies Financial Group lifted their target price on shares of Leidos from $130.00 to $135.00 and gave the stock a “hold” rating in a research report on Wednesday, April 10th. Two investment analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $132.42.

Insiders Place Their Bets

In other Leidos news, Director David G. Fubini sold 7,874 shares of the business’s stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $127.89, for a total value of $1,007,005.86. Following the sale, the director now owns 14,696 shares in the company, valued at approximately $1,879,471.44. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Leidos news, Director David G. Fubini sold 7,874 shares of the business’s stock in a transaction on Wednesday, March 13th. The shares were sold at an average price of $127.89, for a total value of $1,007,005.86. Following the sale, the director now owns 14,696 shares in the company, valued at approximately $1,879,471.44. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Gary Stephen May sold 2,745 shares of the business’s stock in a transaction on Wednesday, February 21st. The stock was sold at an average price of $124.49, for a total transaction of $341,725.05. Following the completion of the sale, the director now owns 11,352 shares in the company, valued at approximately $1,413,210.48. The disclosure for this sale can be found here. Corporate insiders own 0.96% of the company’s stock.

Leidos Profile

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.